Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic optionsUte Fischer, Martin Schrappe, Christina Kratsch et al.|Nature Genetics|2015Cited by 258
A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B‐cell lymphomaMaria Joosten, Volkhard Seitz, Sebastian Ginzel et al.|Molecular Oncology|2016Cited by 15
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targetsJessica I. Hoell, Roland Meisel, Sebastian Ginzel et al.|Blood Advances|2019Cited by 8
Genomic and Drug Response Profiling of Fatal TCF3-HLF-Positive Pediatric Acute Lymphoblastic Leukaemia Identifies Recurrent Mutation Patterns and Novel Therapeutic OptionsJean‐Pierre Bourquin, Björn Stade, Urs Fischer et al.|Unknown|2015Cited by 0